Zobrazeno 1 - 10
of 171
pro vyhledávání: '"Jun-ichi Iga"'
Autor:
Toshiaki Kikuchi, Jun‐ichi Iga, Masato Oosawa, Tatsuya Hoshino, Yoshiya Moriguchi, Miwa Izutsu
Publikováno v:
Neuropsychopharmacology Reports, Vol 44, Iss 2, Pp 321-332 (2024)
Abstract Aims To determine the prevalence and impact of emotional blunting (EB) in patients with major depressive disorder (MDD) in Japan, and identify treatment needs for EB using patients' perceptions and attitudes. Methods Eligible patients in Jap
Externí odkaz:
https://doaj.org/article/55a03af8cb9344baaa6d423af2e93d2f
Autor:
Ayumi Tachibana, Jun-ichi Iga, Tomoki Ozaki, Taku Yoshida, Yuta Yoshino, Hideaki Shimizu, Takaaki Mori, Yoshihiko Furuta, Mao Shibata, Tomoyuki Ohara, Jun Hata, Yasuyuki Taki, Tatsuya Mikami, Tetsuya Maeda, Kenjiro Ono, Masaru Mimura, Kenji Nakashima, Minoru Takebayashi, Toshiharu Ninomiya, Shu-ichi Ueno, the JPSC-AD study group
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-9 (2024)
Abstract In recent years, the association between neuroinflammatory markers and dementia, especially Alzheimer’s disease (AD), has attracted much attention. However, the evidence for the relationship between serum-hs-CRP and dementia including AD a
Externí odkaz:
https://doaj.org/article/afdeb1252aef4f18b812dd9b588c3c6b
Publikováno v:
IBRO Neuroscience Reports, Vol 15, Iss , Pp 281-286 (2023)
Antipsychotic treatment is vital for patients with schizophrenia even in the perinatal period, but the impact at the molecular biological level on offspring is unclear. The aim of the present study was to investigate the effects of intraperitoneal ha
Externí odkaz:
https://doaj.org/article/4f30bae1428343a498dc88f74be62d5d
Autor:
Hirotaka Yamagata, Yuko Fujii, Shinichiro Ochi, Tomoe Seki, Naomi Hasegawa, Hisashi Yamada, Hikaru Hori, Kayo Ichihashi, Jun-ichi Iga, Kazuyoshi Ogasawara, Naoki Hashimoto, Hitoshi Iida, Kazutaka Ohi, Takashi Tsuboi, Shusuke Numata, Akitoyo Hishimoto, Masahide Usami, Eiichi Katsumoto, Hiroyuki Muraoka, Yoshikazu Takaesu, Tatsuya Nagasawa, Hiroshi Komatsu, Kenichiro Miura, Junya Matsumoto, Ken Inada, Shin Nakagawa, Ryota Hashimoto
Publikováno v:
Psychiatry Research Communications, Vol 4, Iss 1, Pp 100158- (2024)
Reports on polypharmacy strategies for patients with schizophrenia and major depressive disorder (MDD) are scarce. The nationwide Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE) project has been used to t
Externí odkaz:
https://doaj.org/article/45217934166b4aa3b62e84829ebe2f03
Autor:
Naoki Hashimoto, Norio Yasui-Furukori, Naomi Hasegawa, Shuhei Ishikawa, Hikaru Hori, Hitoshi Iida, Kayo Ichihashi, Kenichiro Miura, Junya Matsumoto, Shusuke Numata, Fumitoshi Kodaka, Ryuji Furihata, Kazutaka Ohi, Kazuyoshi Ogasawara, Jun-ichi Iga, Hiroyuki Muraoka, Hiroshi Komatsu, Masahiro Takeshima, Kiyokazu Atake, Mikio Kido, Toshinori Nakamura, Taishiro Kishimoto, Akitoyo Hishimoto, Toshiaki Onitsuka, Tsuyoshi Okada, Shinichiro Ochi, Tatsuya Nagasawa, Manabu Makinodan, Hiroki Yamada, Takashi Tsuboi, Hisashi Yamada, Ken Inada, Koichiro Watanabe, Ryota Hashimoto
Publikováno v:
BMC Psychiatry, Vol 23, Iss 1, Pp 1-9 (2023)
Abstract Background Polypharmacy of additional psychotropics alongside the main treatment drug (antipsychotics in schizophrenia and antidepressants in major depressive disorder) is common in Japan. Our goal is to align psychotropic prescription in Ja
Externí odkaz:
https://doaj.org/article/79ad60b8b7d34dc8aaf4cc4645036c95
Autor:
Hitoshi Iida, Tsuyoshi Okada, Kiyotaka Nemoto, Naomi Hasegawa, Shusuke Numata, Kazuyoshi Ogasawara, Kenichiro Miura, Junya Matsumoto, Hikaru Hori, Jun‐ichi Iga, Kayo Ichihashi, Naoki Hashimoto, Hisashi Yamada, Kazutaka Ohi, Norio Yasui‐Furukori, Kentaro Fukumoto, Takashi Tsuboi, Masahide Usami, Ryuji Furihata, Yoshikazu Takaesu, Akitoyo Hishimoto, Hiroyuki Muraoka, Eiichi Katsumoto, Tatsuya Nagasawa, Shinichiro Ochi, Hiroshi Komatsu, Saya Kikuchi, Masahiro Takeshima, Toshiaki Onitsuka, Shinichiro Tamai, Chika Kubota, Ken Inada, Koichiro Watanabe, Hiroaki Kawasaki, Ryota Hashimoto
Publikováno v:
Neuropsychopharmacology Reports, Vol 43, Iss 1, Pp 23-32 (2023)
Abstract To disseminate, educate, and validate psychiatric clinical practice guidelines, the Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE) project was launched in 2016. In this study, we investigated wh
Externí odkaz:
https://doaj.org/article/c820559fc7e94540bdb8071d874d0421
Autor:
Ken Inada, Kentaro Fukumoto, Naomi Hasegawa, Yuka Yasuda, Hisashi Yamada, Hikaru Hori, Kayo Ichihashi, Hitoshi Iida, Kazutaka Ohi, Hiroyuki Muraoka, Fumitoshi Kodaka, Kenta Ide, Naoki Hashimoto, Jun‐ichi Iga, Kazuyoshi Ogasawara, Kiyokazu Atake, Yoshikazu Takaesu, Tatsuya Nagasawa, Hiroshi Komatsu, Tsuyoshi Okada, Ryuji Furihata, Mikio Kido, Saya Kikuchi, Chika Kubota, Manabu Makinodan, Shinichiro Ochi, Masahiro Takeshima, Hirotaka Yamagata, Junya Matsumoto, Kenichiro Miura, Masahide Usami, Taishiro Kishimoto, Toshiaki Onitsuka, Eiichi Katsumoto, Akitoyo Hishimoto, Shusuke Numata, Norio Yasui‐Furukori, Koichiro Watanabe, Ryota Hashimoto
Publikováno v:
Neuropsychopharmacology Reports, Vol 42, Iss 4, Pp 502-509 (2022)
Abstract Aims The Guidelines for the Pharmacotherapy of Schizophrenia were established to improve the quality of medical care, and the EGUIDE project was conducted to train clinicians on guideline usage. A quality indicator (QI) was established to me
Externí odkaz:
https://doaj.org/article/71db657687454769b1c8f814ad0c4bbd
Autor:
Yoshitaka Kyou, Norio Yasui-Furukori, Naomi Hasegawa, Kenta Ide, Kayo Ichihashi, Naoki Hashimoto, Hikaru Hori, Yoshihito Shimizu, Yayoi Imamura, Hiroyuki Muraoka, Hitoshi Iida, Kazutaka Ohi, Yuka Yasuda, Kazuyoshi Ogasawara, Shusuke Numata, Jun-ichi Iga, Takashi Tsuboi, Shinichiro Ochi, Fumitoshi Kodaka, Ryuji Furihata, Toshiaki Onitsuka, Manabu Makinodan, Hiroshi Komatsu, Masahiro Takeshima, Chika Kubota, Akitoyo Hishimoto, Kiyokazu Atake, Hirotaka Yamagata, Mikio Kido, Tatsuya Nagasawa, Masahide Usami, Taishiro Kishimoto, Saya Kikuchi, Junya Matsumoto, Kenichiro Miura, Hisashi Yamada, Koichiro Watanabe, Ken Inada, Ryota Hahimoto
Publikováno v:
Annals of General Psychiatry, Vol 21, Iss 1, Pp 1-8 (2022)
Abstract Background Several guidelines recommend monotherapy in pharmacotherapy for schizophrenia and major depressive disorder. The content of regular prescriptions has been reported in several studies, but not enough research has been conducted on
Externí odkaz:
https://doaj.org/article/73ffe19110cd4489b776e7d60d078acf
Autor:
Kenji Maki, Tomoyuki Ohara, Jun Hata, Mao Shibata, Naoki Hirabayashi, Takanori Honda, Satoko Sakata, Yoshihiko Furuta, Masato Akiyama, Keisuke Yamasaki, Yasuko Tatewaki, Yasuyuki Taki, Takanari Kitazono, Tatsuya Mikami, Tetsuya Maeda, Kenjiro Ono, Masaru Mimura, Kenji Nakashima, Jun-ichi Iga, Minoru Takebayashi, Toshiharu Ninomiya, Shigeyuki Nakaji, Koichi Murashita, Songee Jung, Mina Misawa, Naoki Ishizuka, Hiroshi Akasaka, Yasuo Terayama, Hisashi Yonezawa, Junko Takahashi, Moeko Noguchi-Shinohara, Junji Komatsu, Shutaro Shibata, Sohshi Yuki-Nozaki, Shogyoku Bun, Hidehito Niimura, Ryo Shikimoto, Hisashi Kida, Yasuyo Fukada, Hisanori Kowa, Toshiya Nakano, Kenji Wada, Masafumi Kishi, Tomoki Ozaki, Ayumi Tachibana, Yuta Yoshino, Jun-ichi Iga Shu-ichi Ueno, Tomohisa Ishikawa, Seiji Yuki, Asuka Koyama, Naoto Kajitani, Mamoru Hashimoto, Manabu Ikeda, Yoshihiro Kokubo, Kazuhiro Uchida, Midori Esaki, Benjamin Thyreau, Koji Yonemoto, Hisako Yoshida, Kaori Muto, Yusuke Inoue, Izen Ri, Yukihide Momozawa, Chikashi Terao, Michiaki Kubo, Yutaka Kiyohara
Publikováno v:
Kidney Medicine, Vol 5, Iss 3, Pp 100593- (2023)
Rationale & Objective: Chronic kidney disease, defined by albuminuria and/or reduced estimated glomerular filtration rate (eGFR), has been reported to be associated with brain atrophy and/or higher white matter lesion volume (WMLV), but there are few
Externí odkaz:
https://doaj.org/article/f949a496ee634343aad2d9f87a576ac3
Autor:
Yumi Aoki, Yoshikazu Takaesu, Hajime Baba, Jun‐ichi Iga, Hikaru Hori, Takeshi Inoue, Kazuo Mishima, Aran Tajika, Masaki Kato
Publikováno v:
Neuropsychopharmacology Reports, Vol 42, Iss 3, Pp 306-314 (2022)
Abstract Aim While evidence‐based antidepressant treatment is available for major depressive disorder, standard approaches for discontinuation of antidepressants after remission have not yet been established. Decision aids are structured clinical t
Externí odkaz:
https://doaj.org/article/dfbc156f9049413f839e36721145537b